QA/RA Perspectives: Stina Gustafsson

November 17, 2026
Stina Experts QA RA

Planning ahead to help good ideas reach the market

A good idea and a strong technical solution are not always enough to bring a medical device to market. Understanding regulatory requirements, finding the right expertise and managing the costs involved can present significant challenges.

For Stina Gustafsson, Senior QA/RA Consultant at GBA Key2Compliance, these are some of the biggest obstacles companies face today. She sees companies with promising products struggle to reach the market because they lack the QA/RA competence or financial resources needed.

Stina has more than 20 years of experience in the medical device industry, spanning quality assurance, regulatory affairs, project management, training and product development. Her background includes work with embedded and stand-alone software and mobile apps in a variety of corporate and consulting environments. Since 2018 she has been with GBA Key2Compliance, helping clients build quality management systems, compile technical documentation and deliver training.

Understanding the time and cost involved

One common mistake Stina encounters is underestimating the time and cost of quality and regulatory work.

Implementing a quality management system, preparing and reviewing technical documentation, and completing registration all require time and resources. Alongside the complexity of understanding and following regulatory requirements, Stina highlights continuous monitoring, updating and regular review costs as significant challenges.

Her advice to companies is straightforward:

“Plan ahead as far as possible and look for support in areas where you might not have the competency in-house.”

For Stina, planning ahead and recognising where additional expertise is needed are practical considerations for companies working towards market access.

Document decisions to keep discussions moving forward

Asked about the most valuable lesson she has learned from supporting clients, Stina points to a simple working practice:

“Document all decisions to ensure clarity and to avoid unnecessary repetition of the same discussion.”

The emphasis is on clarity: keeping a record of what has been decided so that the same discussion does not need to be repeated unnecessarily.

It is a practical lesson that reflects the structured way of working she brings to QA and RA.

Exploring AI with careful review

Looking ahead, Stina encourages companies to monitor developments in AI regulation, alongside updates regarding MDR and IVDR.

She also sees opportunities to use AI assistance when working with documentation. Her advice is to benefit from those possibilities while remaining aware of the limitations: everything produced with AI assistance needs to be reviewed and confirmed.

Her perspective combines an interest in what the tools can offer with a clear expectation that their output must be checked.

A structured approach with a practical purpose

What originally drew Stina to QA and RA was the opportunity to enable useful medical devices to reach the market, combined with her own structured, organisational mindset.

That purpose remains the most rewarding part of her work:

“The possibility to contribute to getting useful medical devices to the market.”

Her advice brings that motivation back to everyday practice: plan as far ahead as possible, seek support where expertise is missing, and document decisions clearly. These are the practical priorities she shares with companies working to bring their products to market.

Facing a QA or regulatory challenge?

At GBA Key2Compliance, our consultants combine regulatory expertise with practical industry experience to support medical device and IVD companies throughout the product lifecycle.

Get in touch with us to discuss how we can support you with your QA or regulatory needs.

Search

Search